
November 24, 2017 - By Ellis Scott
Among 3 analysts covering Movado Group (NYSE:MOV), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Movado Group has $34 highest and $32.0 lowest target. $33’s average target is 11.68% above currents $29.55 stock price. Movado Group had 7 analyst reports since August 17, 2015 according to SRatingsIntel. The stock of Movado Group, Inc (NYSE:MOV) has “Hold” rating given on Wednesday, October 11 by KeyBanc Capital Markets. The firm has “Buy” rating by Sidoti given on Monday, January 30. Zacks downgraded the stock to “Hold” rating in Monday, August 17 report. The firm earned “Hold” rating on Tuesday, November 21 by Cowen & Co. On Friday, February 19 the stock rating was initiated by Sidoti with “Buy”. The rating was upgraded by Zacks on Thursday, August 27 to “Sell”. The stock of Movado Group, Inc (NYSE:MOV) has “Neutral” rating given on Thursday, December 15 by Sidoti.Honeywell International Inc decreased Astrazeneca Plc (AZN) stake by 35.48% reported in 2017Q2 SEC filing. Honeywell International Inc sold 165,000 shares as Astrazeneca Plc (AZN)’s stock rose 16.26%. The Honeywell International Inc holds 300,000 shares with $10.23M value, down from 465,000 last quarter. Astrazeneca Plc now has $84.33B valuation. The stock declined 0.41% or $0.14 reaching $33.69 per share. About 8,600 shares traded. AstraZeneca plc (ADR) (NYSE:AZN) has risen 19.45% since November 24, 2016 and is uptrending. It has outperformed by 2.75% the S&P500.Analysts await Movado Group, Inc (NYSE:MOV) to report earnings on November, 28. They expect $0.86 EPS, down 5.49% or $0.05 from last year’s $0.91 per share. MOV’s profit will be $19.73 million for 8.59 P/E if the $0.86 EPS becomes a reality. After $0.43 actual EPS reported by Movado Group, Inc for the previous quarter, Wall Street now forecasts 100.00% EPS growth. Movado Group, Inc. designs, sources, markets and distributes watches. The company has market cap of $677.88 million. The Firm operates through two divisions: Wholesale and Retail. It has a 28.79 P/E ratio. The Wholesale segment includes the design, development, sourcing, marketing and distribution of watches, and after-sales service activities and shipping.Investors sentiment decreased to 0.95 in 2017 Q2. Its down 0.57, from 1.52 in 2017Q1. It dropped, as 20 investors sold Movado Group, Inc shares while 45 reduced holdings. 21 funds opened positions while 41 raised stakes. 14.66 million shares or 1.12% more from 14.49 million shares in 2017Q1 were reported. Virginia Retirement Et Al invested 0.01% in Movado Group, Inc (NYSE:MOV). Cacti Asset Mgmt Limited Company invested in 0.11% or 49,775 shares. Renaissance Technology Ltd Liability stated it has 119,500 shares. Teton Advsrs has 0.16% invested in Movado Group, Inc (NYSE:MOV). Ls Investment Limited Co invested 0% in Movado Group, Inc (NYSE:MOV). Prudential Fin Incorporated holds 0.01% or 203,530 shares in its portfolio. Guggenheim Lc reported 27,917 shares or 0% of all its holdings. Moreover, Tfs Limited Liability Corporation has 0.36% invested in Movado Group, Inc (NYSE:MOV). Systematic Fincl L P stated it has 0.03% in Movado Group, Inc (NYSE:MOV). Tci Wealth Advsrs Inc reported 27 shares or 0% of all its holdings. Vanguard Grp holds 1.55 million shares or 0% of its portfolio. Ameriprise Financial Inc holds 326,376 shares. Acadian Asset Management Lc, a Massachusetts-based fund reported 26,944 shares. Schroder Invest Mngmt Grp Inc accumulated 0% or 9,130 shares. Metropolitan Life Insur has invested 0% of its portfolio in Movado Group, Inc (NYSE:MOV).The stock decreased 0.17% or $0.05 on November 22, reaching $29.55. About shares traded. Movado Group, Inc (NYSE:MOV) has declined 5.74% since November 24, 2016 and is downtrending. It has underperformed by 22.44% the S&P500.Analysts await AstraZeneca plc (ADR) (NYSE:AZN) to report earnings on February, 1. They expect $0.47 earnings per share, down 61.16% or $0.74 from last year’s $1.21 per share. AZN’s profit will be $1.18 billion for 17.92 P/E if the $0.47 EPS becomes a reality. After $1.12 actual earnings per share reported by AstraZeneca plc (ADR) for the previous quarter, Wall Street now forecasts -58.04% negative EPS growth. Among 24 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 14 have Buy rating, 0 Sell and 10 Hold. Therefore 58% are positive. AstraZeneca plc (ADR) had 39 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, September 6 by BMO Capital Markets. As per Friday, September 18, the company rating was upgraded by Bryan Garnier & Cie. Credit Suisse downgraded AstraZeneca plc (ADR) (NYSE:AZN) on Tuesday, October 20 to “Underperform” rating. Credit Suisse upgraded AstraZeneca plc (ADR) (NYSE:AZN) on Friday, May 12 to “Neutral” rating. The rating was downgraded by Leerink Swann to “Hold” on Thursday, July 27. Leerink Swann maintained it with “Market Perform” rating and $34 target in Monday, May 2 report. The stock has “Hold” rating by Cowen & Co on Thursday, July 27. BNP Paribas downgraded the stock to “Neutral” rating in Wednesday, September 14 report. The rating was maintained by Cowen & Co with “Hold” on Monday, October 16. The stock has “Outperform” rating by Leerink Swann on Friday, December 9.Honeywell International Inc increased Allergan Plc stake by 20,100 shares to 168,130 valued at $40.87 million in 2017Q2. It also upped Alexandria Real Estate Equities Inc (NYSE:ARE) stake by 5,900 shares and now owns 27,365 shares. Macerich Co Reit (NYSE:MAC) was raised too. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.


var data = "63557954";
document.write('<ins class="adsbygoogle" style="background-color:transparent; display:inline-block;width:300px;height:600px;" data-ad-client="ca-pub-16900'+data+'675" data-ad-slot="7169126944"></ins>')

(adsbygoogle = window.adsbygoogle || []).push({});